Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Depreciation & Amortization (CF) (2016 - 2025)

Anaptysbio's Depreciation & Amortization (CF) history spans 10 years, with the latest figure at $131000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 9.66% year-over-year to $131000.0; the TTM value through Dec 2025 reached $559000.0, down 7.76%, while the annual FY2025 figure was $559000.0, 7.76% down from the prior year.
  • Depreciation & Amortization (CF) reached $131000.0 in Q4 2025 per ANAB's latest filing, down from $140000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $184000.0 in Q4 2022 to a low of $125000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $155550.0, with a median of $161000.0 recorded in 2021.
  • Peak YoY movement for Depreciation & Amortization (CF): increased 29.6% in 2022, then decreased 12.12% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $165000.0 in 2021, then increased by 11.52% to $184000.0 in 2022, then dropped by 10.33% to $165000.0 in 2023, then fell by 12.12% to $145000.0 in 2024, then fell by 9.66% to $131000.0 in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Depreciation & Amortization (CF) are $131000.0 (Q4 2025), $140000.0 (Q3 2025), and $142000.0 (Q2 2025).